11.38
Integra Lifesciences Holdings Corp stock is traded at $11.38, with a volume of 386.78K.
It is down -0.70% in the last 24 hours and down -22.91% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$11.49
Open:
$11.39
24h Volume:
386.78K
Relative Volume:
0.32
Market Cap:
$889.74M
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
22.77
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
-26.67%
1M Performance:
-22.91%
6M Performance:
-32.28%
1Y Performance:
-52.69%
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IART
Integra Lifesciences Holdings Corp
|
11.42 | 894.98M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
125.56 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.71 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
361.68 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.08 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.59 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Why Integra LifeSciences (IART) Shares Are Trading Lower Today - Yahoo Finance
Integra Lifesciences (IART) Sees Revised Analyst Ratings Today | IART Stock News - GuruFocus
Is Integra LifeSciences Holdings Corporation (IL3) stock a top pick for value investors2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Integra LifeSciences Holdings Corporation stock trend forecastMarket Volume Summary & Long Hold Capital Preservation Tips - newser.com
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond marketQuarterly Profit Review & Capital Efficiency Focused Strategies - newser.com
Published on: 2025-11-03 05:22:14 - newser.com
Does Integra LifeSciences Holdings Corporation show high probability of rebound2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Published on: 2025-11-02 20:58:58 - newser.com
Will Integra LifeSciences Holdings Corporation (IL3) stock profit from AI boomLong Setup & Free Growth Oriented Trading Recommendations - newser.com
Is Integra LifeSciences Holdings Corporation stock vulnerable to regulatory risksMarket Rally & Safe Entry Trade Reports - newser.com
Integra LifeSciences (IART): Deep Losses and Discounted Valuation Shape Sentiment Ahead of Earnings - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Price Target Cut to $11.00 by Analysts at Citigroup - MarketBeat
Integra LifeSciences Hits 52-Week Low at USD 11.05 Amidst Decline - Markets Mojo
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2025 Earnings Call Transcript - Insider Monkey
Integra LifeSciences (NASDAQ:IART) Hits New 52-Week LowHere's What Happened - MarketBeat
How buyback programs support Integra LifeSciences Holdings Corporation (IL3) stockIndex Update & Safe Swing Trade Setup Alerts - newser.com
Is Integra LifeSciences Holdings Corporation stock poised for growthWeekly Market Outlook & Weekly Stock Performance Updates - newser.com
Technical signs of recovery in Integra LifeSciences Holdings CorporationJuly 2025 Breakouts & Reliable Price Breakout Alerts - newser.com
Intraday pattern recognizer results for Integra LifeSciences Holdings CorporationOptions Play & Reliable Entry Point Trade Alerts - newser.com
Integra LifeSciences (NASDAQ:IART) Issues Earnings Results - MarketBeat
Integra LifeSciences (NASDAQ:IART) Trading Down 23.2%What's Next? - MarketBeat
Citigroup Maintains "Sell" Rating on Integra Lifesciences (IART) with Lowered Price Target | IART Stock News - GuruFocus
Integra LifeSciences Hits Day Low of $11.05 Amid Price Pressure - Markets Mojo
JP Morgan Raises Price Target for Integra Lifesciences (IART) to $13 | IART Stock News - GuruFocus
Integra LifeSciences (NASDAQ:IART) Releases Q4 2025 Earnings Guidance - MarketBeat
Does Integra LifeSciences Holdings Corporation qualify in momentum factor screeningJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com
How to use Fibonacci retracement on Integra LifeSciences Holdings CorporationQuarterly Risk Review & Daily Chart Pattern Signal Reports - newser.com
Integra: Q3 Earnings Snapshot - Stamford Advocate
Is Integra LifeSciences Holdings Corporation stock undervalued vs historical averagesWeekly Market Outlook & Entry Point Confirmation Signals - newser.com
Will Integra LifeSciences Holdings Corporation stock deliver better than expected guidance - newser.com
Integra LifeSciences Holdings Corporation (IART) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Integra Lifesciences Holdings Corp (IART) Q3 2025 Earnings Call Highlights: Strong EPS Growth ... By GuruFocus - Investing.com Canada
Integra Lifesciences Holdings Corp (IART) Q3 2025 Earnings Call Highlights: Strong EPS Growth ... - Yahoo Finance
Integra LifeSciences Q3 revenue $402,062 amid $511,365 impairment YTD - Stock Titan
Integra Lifesciences Holdings Corp (IART) Q3 2025 Earnings Call - GuruFocus
Integra LifeSciences Drops After Cutting Revenue Outlook - Finimize
Why Integra LifeSciences (IART) Shares Are Sliding Today - Yahoo Finance
Integra LifeSciences (IART) Reports Strong Q3 Despite Supply Cha - GuruFocus
Integra LifeSciences stock hits 52-week low at 11.05 USD - Investing.com
Will Integra LifeSciences Holdings Corporation (IL3) stock gain from lower interest ratesEarnings Recap Report & Consistent Return Strategy Ideas - newser.com
Earnings call transcript: Integra LifeSciences Q3 2025 beats EPS expectations - Investing.com
Integra LifeSciences Q3 Loss Narrows; Cuts FY25 Revenue Guidance; Stock Up - Nasdaq
Integra LifeSciences Holdings C (IART) Q3 FY2025 earnings call transcript - Yahoo Finance
Integra LifeSciences Q3 Adj. EPS Tops Estimates, But Revenues Miss - Nasdaq
Integra LifeSciences Slashes FY25 OutlookUpdate - Nasdaq
Integra LifeSciences (IART) Q3 Earnings Beat Estimates - Yahoo Finance
Integra LifeSciences beats on earnings despite revenue miss - Investing.com
Integra Lifesciences Q3 2025 Earnings: Adjusted EPS of $0.54 Sur - GuruFocus
Integra LifeSciences (IART) Reports Q3 Revenue Below Expectations - GuruFocus
Integra LifeSciences Reports Third Quarter 2025 Financial Results - TradingView
IART furnishes Q3 2025 results with GAAP-to-non-GAAP reconciliations - Stock Titan
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
Integra Lifesciences Holdings Corp Stock (IART) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 11 '25 |
Option Exercise |
0.00 |
2,356 |
0 |
4,391 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
| Schwartz Eric | EVP, Chief Legal Officer & Sec |
Dec 03 '24 |
Sale |
24.59 |
4,070 |
100,102 |
59,511 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):